Clinical trial
Feasibility Evaluation of ONCOhabitats for Supporting Surgical and Therapeutic Planning in Patients With IDH-Wildtype Glioblastoma (SINUE)
NCT07111195 is registered in ClinicalTrials.gov with Juan M Garcia-Gomez as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Feasibility Evaluation of ONCOhabitats for Supporting Surgical and Therapeutic Planning in Patients With IDH-Wildtype Glioblastoma (SINUE)
- Lead sponsor
- Juan M Garcia-Gomez
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- July 16, 2024
- Completion date
- September 30, 2026
- Enrollment
- 140 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
glioblastoma idh (isocitrate dehydrogenase) wildtype